Results 121 to 130 of about 1,963 (217)

Tiotropium bromide step-up therapy for adults with uncontrolled asthma [PDF]

, 2010
Castro, Mario, et al,, Walter, Michael J
core   +2 more sources

Crystallographic Structure, Intermolecular Packing Energetics, Crystal Morphology and Surface Chemistry of Salmeterol Xinafoate (Form I)

, 2016
Alexandru A. Moldovan, Ian Rosbottom, Vasuki Ramachandran, Christopher M. Pask, Oboroghene Olomukhoro, Kevin J. Roberts   +5 more
openalex   +1 more source

The QUALITY BY DESIGN APPROACH FOR SIMULTANEOUS DETERMINATION OF FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE

, 2020
Pankaj N. Kulkarni, Chetan K. Jadhav, ALAKNANDA M. DODAKE-SUPEKAR, Charansingh H. Gill   +3 more
openalex   +2 more sources

P177 Fluticasone propionate/formoterol fumarate combination therapy is as effective as fluticasone propionate/salmeterol xinafoate in the treatment of asthma: a randomised controlled trial [PDF]

, 2010
Anna Bodzenta­‐Łukaszyk, Andrzej Dymek, Heikki Mansikka   +2 more
openalex   +1 more source

FP/FORM Versus FP/SAL Within Clinical Practice: An Updated Budget Impact Analysis in Asthma [PDF]

, 2016

core   +1 more source

Analysis of drug-induced adverse reactions affecting appetite and taste using the Japanese Adverse Drug Event Report Database. [PDF]

BMC Res Notes
Maese M, Kondo S, Sakatsume Y, Takagi M, Yokoyama Y, Iwata H, Kobayashi N, Yamaura K.   +7 more
europepmc   +1 more source

Correlation Analysis of the Therapy Adherence to Long-Acting Inhalers Among Patients with Stable COPD. [PDF]

Patient Prefer Adherence, 2023
Tan X, Liu S, Huang L, Wu Y, Wen L, Liu J, Tang Y, Liu X.   +7 more
europepmc   +1 more source

A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β₂-Agonists Used for Asthma and COPD. [PDF]

Pharmacol Res Perspect
Proudman RGW, Baker JG.
europepmc   +1 more source

Cryptococcal laryngitis in an immunocompetent asthmatic patient using inhaled corticosteroids. [PDF]

Med Mycol Case Rep, 2023
Butel-Simoes GI, Kua H, Safdar A, Graham M, Korman T, Meher-Homji Z.   +5 more
europepmc   +1 more source

Non-antifungal medications administered during fungal infections drive drug tolerance and resistance in <i>Candida albicans</i>. [PDF]

J Med Microbiol
Obermeier M, Esparza-Mora MA, Heese O, Cohen N, Varma SJ, Tober-Lau P, Hartl J, Kurth F, Berman J, Ralser M.   +9 more
europepmc   +1 more source